Technology | Quality Assurance (QA) | October 02, 2015

IBA Releases Version Two of myQA Radiotherapy Quality Assurance Platform

Latest version offers updates to myQA Cloud for online benchmarking, myQA cockpit patient dashboard

IBA, myQA version 2, global quality assurance platform

Image courtesy of Ion Beam Applications S.A.

October 2, 2015 — IBA (Ion Beam Applications S.A.) announced the second release of its myQA global quality assurance platform. The platform connects radiation therapy quality assurance (QA) applications, people and know-how through a central database and the cloud. It offers full support to its users throughout the entire QA workflow, and provides access to all software modules and data from one intuitive interface.

The first version of myQA was released in March 2015, and version two offers enhancements to accompanying products, including myQA Cloud and a new patient dashboard within myQA Cockpit.

myQA Cloud offers users the opportunity to anonymously benchmark their QA data and connect with users from around the world. This online tool not only contributes to best practice checks, but also gives its users full trust in their results.

With the upgrade of myQA Cockpit, users are able to better track, review and maintain their patient QA data on one interface. This new addition allows users to comfortably monitor their patient and machine QA data in one place and on any Web-accessible device.

Being the first and only of it’s kind; myQA is extending the frontiers in highly efficient and effective QA workflows. With the release of the highly anticipated myQA Cloud, the Support Portal, an even more advanced patient dashboard within myQA Cockpit, and much more, the evolution of myQA is proving its commitment to providing users with the latest and most advanced QA solution.

For more information: www.iba-worldwide.com

Related Content

Videos | Radiation Therapy | February 21, 2019
ITN Associate Editor Jeff Zagoudis speaks with Christy Kesslering, M.D., medical director of radiation oncology at th
FDA Clears Advancements for Viewray MRIdian Radiation Therapy System
Technology | Image Guided Radiation Therapy (IGRT) | February 21, 2019
February 21, 2019 — ViewRay Inc. received 510(k) clearance from the U.S.
Videos | Radiation Therapy | February 20, 2019
ITN Associate Editor Jeff Zagoudis speaks with Vinai Gondi, M.D., director of research and CNS neuro-oncology at the
Study Unveils Blueprint for Treating Radiation-Resistant Brain Tumor

NIH-funded researchers showed how gliomas may be treated with radiation and drugs that block DNA repair. Image courtesy of Castro lab, Michigan Medicine, Ann Arbor

 

News | Radiation Therapy | February 19, 2019
February 19, 2019 — Researchers at the University of Michigan recently searched for new brain tumor treatments by exp
Videos | Radiation Therapy | February 15, 2019
ITN Associate Editor Jeff Zagoudis speaks with Vinai Gondi, M.D., director of research and CNS neuro-oncology at the
New Targeted Therapy for Recurrent Brain Tumors Implanted for First Time
News | Radiation Therapy | February 15, 2019
University of Minnesota Health (M Health) is the first in the United States to begin offering GammaTile Therapy, a new...
Canon Adds Radiation Therapy Package to Aquilion Prime, Lightning CT Systems
News | Computed Tomography (CT) | February 11, 2019
In the patient-centric world of radiation oncology, it is critical that computed tomography (CT) simulation is...
Elekta Unity MR-Linac Earns FDA Clearance
Technology | Image Guided Radiation Therapy (IGRT) | February 07, 2019
The Elekta Unity magnetic resonance radiation therapy (MR/RT) system recently received 510(k) premarket notification...
University of Oklahoma Cancer Center Begins First Proton Therapy Treatments
News | Proton Therapy | February 01, 2019
Home to the largest and most comprehensive radiation therapy program in Oklahoma, the Stephenson Cancer Center at OU (...
Stereotactic Radiotherapy Improves Long-Term Survival in Stage-IV Cancers
News | Stereotactic Body Radiation Therapy (SBRT) | January 31, 2019
The first report from a phase II, multi-center clinical trial indicates stereotactic radiation can extend long-term...